Edington CD, Chen WLK, Geishecker E, Kassis T, Soenksen LR, Bhushan BM, Freake D, Kirschner J, Maass C, Tsamandouras N, Valdez J, Cook CD, Parent T, Snyder S, Yu J, Suter E, Shockley M, Velazquez J, Velazquez JJ, Stockdale L, Papps JP, Lee I, Vann N, Gamboa M, LaBarge ME, Zhong Z, Wang X, Boyer LA, Lauffenburger DA, Carrier RL, Communal C, Tannenbaum SR, Stokes CL, Hughes DJ, Rohatgi G, Trumper DL, Cirit M, Griffith LG (2018) Interconnected microphysiological systems for quantitative biology and Pharmacology studies
doi: 10.1515/jpem-2022-0468 71 Lecka-AmbroziakAWysocka-MincewiczMMarszaek-DziubaKRudzka-KocjanASzaleckiM
Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis
The mechanism of action of IGF-1 LR3 is through interaction with IGF-1 receptors that play a role in cellular growth and signaling pathways
Metabolic syndrome-a new world-wide definition
Before starting GLP-1 therapy , schedule a discussion with your healthcare provider if you have Hashimoto's disease
